Camurus AB (publ)

Symbol: 0RD1.L

LSE

504.2706

SEK

Market price today

  • 68.8897

    P/E Ratio

  • -0.5085

    PEG Ratio

  • 29.06B

    MRK Cap

  • 0.00%

    DIV Yield

Camurus AB (publ) (0RD1-L) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.92%

Operating Profit Margin

0.31%

Net Profit Margin

0.25%

Return on Assets

0.23%

Return on Equity

0.32%

Return on Capital Employed

0.35%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Pharmaceuticals
CEO:Mr. Fredrik Tiberg
Full-time employees:213
City:Lund
Address:Ideon Science Park
IPO:2016-05-03
CIK:

Camurus AB (publ), a pharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, Japan, and internationally. The company offers Buvidal, a buprenorphine injection for the treatment of opioid dependence; episil oral liquid, a medical device for the treatment of inflammatory and painful conditions in the oral cavity; and Brixadi to treat opioid use disorder Its products pipeline also includes CAM2038 for the treatment of chronic pain; CAM2029, which is in phase III clinical trials for the treatment of acromegaly and neuroendocrine tumors, as well as in phase II clinical trial to treat polycystic liver diseases; and CAM2043 that is in phase I clinical trial for the treatment of pulmonary arterial hypertension, as well as in Phase II clinical trial to treat Raynaud's phenomenon. In addition, the company is developing CAM2032, which is in phase II clinical trials for the treatment of prostate cancer; CAM4072 that is in phase III clinical trials for the treatment of genetic obesity disorders; CAM4071, which is in phase I clinical trials for the treatment of endocrine disorder; CAM2047 for the treatment of chemotherapy-induced nausea and vomiting that is in phase 1 clinical trial; and CAM2048, which is in phase I clinical trial for postoperative pain. Camurus AB (publ) was founded in 1991 and is headquartered in Lund, Sweden.

General Outlook

When we look at how much money they make before expenses, they keep 0.921% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.310%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.251%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.226% return, is a testament to Camurus AB (publ)'s adeptness in optimizing resource deployment. Camurus AB (publ)'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.318%. Furthermore, the proficiency of Camurus AB (publ) in capital utilization is underscored by a remarkable 0.346% return on capital employed.

Stock Prices

Camurus AB (publ)'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $477, while its low point bottomed out at $459. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Camurus AB (publ)'s stock market.

Liquidity Ratios

Analyzing 0RD1.L liquidity ratios reveals its financial health of the firm. The current ratio of 440.61% gauges short-term asset coverage for liabilities. The quick ratio (408.30%) assesses immediate liquidity, while the cash ratio (322.81%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio440.61%
Quick Ratio408.30%
Cash Ratio322.81%

Profitability Ratios

0RD1.L profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 31.99% underscores its earnings before tax deductions. The effective tax rate stands at 21.46%, revealing its tax efficiency. The net income per EBT, 78.54%, and the EBT per EBIT, 103.18%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 31.01%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin31.99%
Effective Tax Rate21.46%
Net Income per EBT78.54%
EBT per EBIT103.18%
EBIT per Revenue31.01%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 4.41, it details the span from stock purchase to revenue. The 4 days it takes to settle debts showcases its creditor relations. Meanwhile, a 3 cash conversion cycle and 544.81% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding408
Days of Inventory Outstanding270
Operating Cycle337.28
Days of Payables Outstanding266
Cash Conversion Cycle71
Receivables Turnover5.45
Payables Turnover1.37
Inventory Turnover1.35
Fixed Asset Turnover43.27
Asset Turnover0.90

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 10.92, and free cash flow per share, 10.74, depict cash generation on a per-share basis. The cash per share value, 21.42, showcases liquidity position. Lastly, the operating cash flow sales ratio, 0.35, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share10.92
Free Cash Flow per Share10.74
Cash per Share21.42
Operating Cash Flow Sales Ratio0.35
Free Cash Flow to Operating Cash Flow Ratio0.98
Cash Flow Coverage Ratio24.76
Short Term Coverage Ratio55.71
Capital Expenditure Coverage Ratio59.93
Dividend Paid and Capex Coverage Ratio59.93

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 1.28%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.02, we discern the balance between debt and equity financing. The long-term debt to capitalization, 0.90%, and total debt to capitalization, 1.61%, ratios shed light on its capital structure. An interest coverage of 397.58 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio1.28%
Debt Equity Ratio0.02
Long Term Debt to Capitalization0.90%
Total Debt to Capitalization1.61%
Interest Coverage397.58
Cash Flow to Debt Ratio24.76
Company Equity Multiplier1.28

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 30.95, provides a glimpse into top-line earnings distributed across each share. Net income per share, 7.78, reflects the portion of profit attributed to each share. The book value per share, 26.91, represents the net asset value distributed per share, while the tangible book value per share, 26.91, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share30.95
Net Income Per Share7.78
Book Value Per Share26.91
Tangible Book Value Per Share26.91
Shareholders Equity Per Share26.91
Interest Debt Per Share0.47
Capex Per Share-0.18

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 79.52%, indicates top-line expansion, while the gross profit growth, 87.24%, reveals profitability trends. EBIT growth, 654.81%, and operating income growth, 654.81%, offer insights into operational profitability progression. The net income growth, 676.63%, showcases bottom-line expansion, and the EPS growth, 670.30%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth79.52%
Gross Profit Growth87.24%
EBIT Growth654.81%
Operating Income Growth654.81%
Net Income Growth676.63%
EPS Growth670.30%
EPS Diluted Growth642.57%
Weighted Average Shares Growth0.74%
Weighted Average Shares Diluted Growth4.41%
Operating Cash Flow Growth499.69%
Free Cash Flow Growth500.99%
10-Year Revenue Growth per Share294.48%
5-Year Revenue Growth per Share2274.44%
3-Year Revenue Growth per Share385.20%
10-Year Operating CF Growth per Share69.07%
5-Year Operating CF Growth per Share251.04%
3-Year Operating CF Growth per Share341.28%
10-Year Net Income Growth per Share97.51%
5-Year Net Income Growth per Share225.41%
3-Year Net Income Growth per Share344.93%
10-Year Shareholders Equity Growth per Share1255.23%
5-Year Shareholders Equity Growth per Share303.61%
3-Year Shareholders Equity Growth per Share67.29%
Receivables Growth39.82%
Inventory Growth-6.03%
Asset Growth45.94%
Book Value per Share Growth48.99%
Debt Growth-6.52%
R&D Expense Growth34.88%
SGA Expenses Growth37.46%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 28,762,844,190, captures the company's total value, considering both debt and equity. Income quality, 1.41, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.03, gauges operational efficiency, while the research and development to revenue, 37.00%, highlights investment in innovation. The ratio of intangibles to total assets, -11.60%, indicates the value of non-physical assets, and capex to operating cash flow, -1.67%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value28,762,844,190
Income Quality1.41
Sales General and Administrative to Revenue0.03
Research and Development to Revenue37.00%
Intangibles to Total Assets-11.60%
Capex to Operating Cash Flow-1.67%
Capex to Revenue-0.59%
Capex to Depreciation-85.09%
Stock-Based Compensation to Revenue5.98%
Graham Number68.62
Return on Tangible Assets20.26%
Graham Net Net19.14
Working Capital1,255,475,000
Tangible Asset Value1,714,321,000
Net Current Asset Value1,209,250,000
Average Receivables270,257,500
Average Payables92,413,000
Average Inventory104,193,000
Days Sales Outstanding67
Days Payables Outstanding290
Days of Inventory On Hand295
ROIC27.55%
ROE0.29%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 19.91, and the price to book ratio, 19.91, reflect the market's valuation relative to the company's book value. The price to sales ratio, 17.96, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 51.66, and price to operating cash flows, 48.98, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio19.91
Price to Book Ratio19.91
Price to Sales Ratio17.96
Price Cash Flow Ratio48.98
Price Earnings to Growth Ratio-0.51
Enterprise Value Multiple58.56
Price Fair Value19.91
Price to Operating Cash Flow Ratio48.98
Price to Free Cash Flows Ratio51.66
Price to Tangible Book Ratio20.05
Enterprise Value to Sales16.75
Enterprise Value Over EBITDA52.85
EV to Operating Cash Flow47.39
Earnings Yield1.44%
Free Cash Flow Yield1.99%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Camurus AB (publ) (0RD1.L) on the LSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 68.890 in 2024.

What is the ticker symbol of Camurus AB (publ) stock?

The ticker symbol of Camurus AB (publ) stock is 0RD1.L.

What is company IPO date?

IPO date of Camurus AB (publ) is 2016-05-03.

What is company current share price?

Current share price is 504.271 SEK.

What is stock market cap today?

The market cap of stock today is 29057887346.000.

What is PEG ratio in 2024?

The current -0.508 is -0.508 in 2024.

What is the number of employees in 2024?

In 2024 the company has 213.